Electrode | Type of sample | Sensitivity (µA mM− 1 cm− 2) | Linear range (mM) | Detection limit (µM) | References | ||||
---|---|---|---|---|---|---|---|---|---|
From | To | ||||||||
Copper–graphene nano–composite | Human serum sample | 11.3 | 0.9 | 11 | 1 | [33] | |||
Electrochemically reduced graphene oxide (ERGO)/Cu/GCE | Human blood sample | 445 | 0.00014 | 5.091 | 0.049 | [34] | |||
CuO NWs/SWCNTs/ GCE | Human serum diluted 20 times by 50 mM NaOH | 761.5 | 0.034 | 2.67 | 0.0456 | [35] | |||
Cu@C composite nanotube array | 0.5 mM glucose in NaOH | 1200 | 0.001 | 0.06 | 1 | [36] | |||
3D Cu@Cu2O aerogels 0.1 M NaOH) | Human serum sample | 194.88 | 0.001 | 17.12 | 0.6 | [37] | |||
Cu2O microcrystals | Glucose solution | 97 | 0 | 14.3 | 0.33 | [38] | |||
Cu–MOF | Glucose solution | 89 | 0.00006 | 5 | 0.0105 | [39] | |||
CuO–350–NA/GCE | Fusayama’s artificial saliva | 18.061 | 0 | 6.535 | 0.15 | [40] | |||
Cu–MOF/MWNTs | Human serum sample | 3878 | 0.0005 | 2.34 | 0.4 | [41] | |||
Cu2O/AlOOH/rGO | Glucose solution | 155.1 | 0.005 | 14.77 | 2.6 | [42] | |||
CuO | 0.1 M NaOH with different concentrations of glucose | 168.7 | 0 | 2 | 10 | [43] | |||
MOF derived CuO/C–400oC | Human blood sample | 244.71 | 0.005 | 25.325 | 1 | This work |